BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, Walsh SL, White ES, Richeldi L. The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. Lancet Respir Med 2017;5:61-71. [PMID: 27932290 DOI: 10.1016/S2213-2600(16)30325-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Fytianos K, Schliep R, Mykoniati S, Khan P, Hostettler KE, Tamm M, Gazdhar A, Knudsen L, Geiser T. Anti-Fibrotic Effect of SDF-1β Overexpression in Bleomycin-Injured Rat Lung. Pharmaceutics 2022;14:1803. [DOI: 10.3390/pharmaceutics14091803] [Reference Citation Analysis]
2 Bao H, Cheng S, Li X, Li Y, Yu C, Huang J, Zhang Z. Functional Au nanoparticles for engineering and long-term CT imaging tracking of mesenchymal stem cells in idiopathic pulmonary fibrosis treatment. Biomaterials 2022;:121731. [PMID: 35970616 DOI: 10.1016/j.biomaterials.2022.121731] [Reference Citation Analysis]
3 Wu X, Chen C, Chen XM, Luo CN, Lv X, Shi YM, Yang J, Meng XY, Chen C, Su JM, Wu LJ. Raman spectroscopy combined with machine learning algorithms for rapid detection Primary Sjögren's syndrome associated with interstitial lung disease. Photodiagnosis and Photodynamic Therapy 2022. [DOI: 10.1016/j.pdpdt.2022.103057] [Reference Citation Analysis]
4 Yu WK, Chen WC, Su VY, Shen HC, Wu HH, Chen H, Yang KY. Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction. Int J Mol Sci 2022;23:8193. [PMID: 35897764 DOI: 10.3390/ijms23158193] [Reference Citation Analysis]
5 Hoyer N, Prior TS, Bendstrup E, Shaker SB. Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates. BMJ Open Respir Res 2022;9:e001276. [PMID: 35798532 DOI: 10.1136/bmjresp-2022-001276] [Reference Citation Analysis]
6 Glass DS, Grossfeld D, Renna HA, Agarwala P, Spiegler P, DeLeon J, Reiss AB. Idiopathic pulmonary fibrosis: Current and future treatment. Clin Respir J 2022;16:84-96. [PMID: 35001525 DOI: 10.1111/crj.13466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yang D, Xu P, Su H, Zhong W, Xu J, Su Z, Liu X. The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis. Cell Death Dis 2022;13:60. [PMID: 35039472 DOI: 10.1038/s41419-021-04365-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Skurikhin E, Madonov P, Pershina O, Ermakova N, Pakhomova A, Widera D, Pan E, Zhukova M, Sandrikina L, Artamonov A, Dygai A. Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis. Int J Mol Sci 2021;22:5599. [PMID: 34070506 DOI: 10.3390/ijms22115599] [Reference Citation Analysis]
9 Gao J, Kalafatis D, Carlson L, Pesonen IHA, Li CX, Wheelock Å, Magnusson JM, Sköld CM. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry. Respir Res 2021;22:40. [PMID: 33546682 DOI: 10.1186/s12931-021-01634-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Löfdahl A, Tornling G, Wigén J, Larsson-Callerfelt AK, Wenglén C, Westergren-Thorsson G. Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. Int J Mol Sci 2020;22:E225. [PMID: 33379351 DOI: 10.3390/ijms22010225] [Reference Citation Analysis]
11 Ramadurai D, Corder S, Churney T, Graney B, Harshman A, Meadows S, Swigris JJ. Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers. Chron Respir Dis 2019;16:1479973119858961. [PMID: 31288534 DOI: 10.1177/1479973119858961] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
12 Bondesson D, Schneider MJ, Silbernagel E, Behr J, Reichenberger F, Dinkel J. Automated evaluation of probe-based confocal laser endomicroscopy in the lung. PLoS One 2020;15:e0232847. [PMID: 32374768 DOI: 10.1371/journal.pone.0232847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Smargiassi A, Inchingolo R, Calandriello L, Lombardi F, Calabrese A, Siciliano M, Larici AR, Demi L, Richeldi L, Soldati G. Possible Role of Chest Ultrasonography for the Evaluation of Peripheral Fibrotic Pulmonary Changes in Patients Affected by Idiopathic Pulmonary Fibrosis—Pilot Case Series. Applied Sciences 2020;10:1617. [DOI: 10.3390/app10051617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S, Fernandez R, Akbarpour M, Chen CI, Ren Z, Verma R, Abdala-Valencia H, Nam K, Chi M, Han S, Gonzalez-Gonzalez FJ, Soberanes S, Watanabe S, Williams KJN, Flozak AS, Nicholson TT, Morgan VK, Winter DR, Hinchcliff M, Hrusch CL, Guzy RD, Bonham CA, Sperling AI, Bag R, Hamanaka RB, Mutlu GM, Yeldandi AV, Marshall SA, Shilatifard A, Amaral LAN, Perlman H, Sznajder JI, Argento AC, Gillespie CT, Dematte J, Jain M, Singer BD, Ridge KM, Lam AP, Bharat A, Bhorade SM, Gottardi CJ, Budinger GRS, Misharin AV. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis. Am J Respir Crit Care Med 2019;199:1517-36. [PMID: 30554520 DOI: 10.1164/rccm.201712-2410OC] [Cited by in Crossref: 373] [Cited by in F6Publishing: 229] [Article Influence: 186.5] [Reference Citation Analysis]
15 Prayer F, Röhrich S, Pan J, Hofmanninger J, Langs G, Prosch H. [Artificial intelligence in lung imaging]. Radiologe 2020;60:42-7. [PMID: 31754738 DOI: 10.1007/s00117-019-00611-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zhang J, Wang Y, Zhang S, Li J, Fang H. Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF-β1 and MMP-7 in silicosis patients. Exp Ther Med 2020;19:2195-201. [PMID: 32104284 DOI: 10.3892/etm.2020.8431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ranzieri S, Illica Magrini E, Mozzoni P, Andreoli R, Pelà G, Bertorelli G, Corradi M. Idiopathic pulmonary fibrosis and occupational risk factors. Med Lav 2019;110:407-36. [PMID: 31846447 DOI: 10.23749/mdl.v110i6.8970] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Nezka H, Igor P, Izidor K. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection. Radiol Oncol 2019;53:357-61. [PMID: 31553706 DOI: 10.2478/raon-2019-0032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Hoyer N, Prior TS, Bendstrup E, Wilcke T, Shaker SB. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis. Respir Res 2019;20:103. [PMID: 31126287 DOI: 10.1186/s12931-019-1076-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
20 Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Hashisako M, Tanaka T, Terasaki Y, Kunugi S, Kitani M, Okuda R, Horiike Y, Enomoto Y, Yasui H, Hozumi H, Suzuki Y, Nakamura Y, Fukuoka J, Johkoh T, Kondoh Y, Ogura T, Inoue Y, Hasegawa Y, Inase N, Homma S, Suda T. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion. Eur Respir J 2019;53:1802243. [PMID: 30880283 DOI: 10.1183/13993003.02243-2018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 7.7] [Reference Citation Analysis]
21 Han Q, Wang HY, Zhang XX, Wu LL, Wang LL, Jiang Y, Deng KM, Mao MM, Chen RC, Kolb M, Luo Q. The Role of Follow-up Evaluation in the Diagnostic Algorithm of Idiopathic Interstitial Pneumonia: A Retrospective Study. Sci Rep 2019;9:6452. [PMID: 31015608 DOI: 10.1038/s41598-019-42813-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Liu G, Wang Y, Yang L, Zou B, Gao S, Song Z, Lin Z. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis. J Cell Mol Med 2019;23:3583-96. [PMID: 30869194 DOI: 10.1111/jcmm.14258] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
23 Xiong Y, Nie D, Liu S, Ma H, Su S, Sun A, Zhao J, Zhang Z, Xiang X, Tang G. Apoptotic PET Imaging of Rat Pulmonary Fibrosis With [18F]ML-8. Mol Imaging 2018;17:1536012118795728. [PMID: 30348035 DOI: 10.1177/1536012118795728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Algranti E, Saito CA, Silva DRME, Carneiro APS, Bussacos MA. Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014. J Bras Pneumol 2017;43:445-50. [PMID: 29340493 DOI: 10.1590/S1806-37562017000000035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Hochhegger B, Marchiori E, Zanon M, Rubin AS, Fragomeni R, Altmayer S, Carvalho CRR, Baldi BG. Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics. Clinics (Sao Paulo) 2019;74:e225. [PMID: 30726312 DOI: 10.6061/clinics/2019/e225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
26 Hayton C, Terrington D, Wilson AM, Chaudhuri N, Leonard C, Fowler SJ. Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review. Respir Res 2019;20:7. [PMID: 30634961 DOI: 10.1186/s12931-019-0971-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
27 Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, Müller V, Bonniaud P, Vancheri C, Wells A, Vasakova M, Pesci A, Sofia M, Klepetko W, Seeger W, Drakopanagiotakis F, Crestani B. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res 2018;19:141. [PMID: 30055613 DOI: 10.1186/s12931-018-0845-5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 118] [Article Influence: 25.3] [Reference Citation Analysis]
28 Spagnolo P, Tzouvelekis A, Bonella F. The Management of Patients With Idiopathic Pulmonary Fibrosis. Front Med (Lausanne) 2018;5:148. [PMID: 30013972 DOI: 10.3389/fmed.2018.00148] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
29 Prazeres PHDM, Turquetti AOM, Azevedo PO, Barreto RSN, Miglino MA, Mintz A, Delbono O, Birbrair A. Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis. Int J Biochem Cell Biol 2018;99:109-13. [PMID: 29627438 DOI: 10.1016/j.biocel.2018.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
30 Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res 2018;19:32. [PMID: 29471816 DOI: 10.1186/s12931-018-0730-2] [Cited by in Crossref: 130] [Cited by in F6Publishing: 180] [Article Influence: 32.5] [Reference Citation Analysis]
31 Wang Y, Yella J, Chen J, McCormack FX, Madala SK, Jegga AG. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers. BMC Pulm Med 2017;17:133. [PMID: 29058630 DOI: 10.1186/s12890-017-0472-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]